Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections.

内在免疫原性是SARS-CoV-2感染中类型特异性反应的主要决定因素

阅读:7
作者:Quirk Grace E, Schoenle Marta V, Peyton Kameron L, Uhrlaub Jennifer L, Lau Branden, Liang Chieh-Yu, Burgess Jefferey L, Ellingson Katherine, Beitel Shawn, Romine James, Lutrick Karen, Fowlkes Ashley, Britton Amadea, Tyner Harmony L, Caban-Martinez Alberto J, Naleway Allison, Gaglani Manjusha, Yoon Sarang, Edwards Laura J, Olsho Lauren, Dake Michael, Valdez Riccardo, Gordon Aubree, Diamond Michael S, LaFleur Bonnie J, Nikolich Janko Ž, Sprissler Ryan, Worobey Michael, Bhattacharya Deepta
Few type-specific antibodies that recognize drifted epitopes are made during post-vaccination exposures to SARS-CoV-2 variants(1-12), perhaps due to suppression by previous immunity. We compared type-specific B cell responses in unvaccinated and vaccinated individuals with Delta and Omicron BA.1 SARS-CoV-2 variant infections. For both Delta, which is antigenically similar to the vaccine strain, and the more distant BA.1 variant, neutralizing antibodies were greater in post-vaccination variant infections than in primary variant infections. Delta type-specific memory B cells were reduced in post-vaccination Delta infections relative to primary variant infections. Yet some drifted epitopes in the Delta variant elicited minimal responses even in primary infections. For BA.1 infections, type-specific antibodies and memory B cells were mostly undetectable, irrespective of previous immunity. Thus, poor intrinsic antigenicity of drifted epitopes in Delta and BA.1 infections superseded the impact of previous immunity. Enhancing the immunogenicity of vaccine antigens may promote type-specific responses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。